(Q46152824)

English

A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity

scientific article published in September 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

1 reference

PHPIZROJYXXSHW-XDEKXSDFSA-N

1 reference

author name string

Ryo Murakami

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Yoko Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Masaaki Kizuka

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Tomoka Kagawa

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Yasunori Muramatsu

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Shunichi Miyakoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Toshio Takatsu

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

Masatoshi Inukai

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

publication date

September 2008

1 reference

16 September 2022

full work available at URL

https://www.nature.com/articles/ja200871.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.71?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

61

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

537-544

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.71?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

21 January 2018

Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

The structure of liposidomycin B, an inhibitor of bacterial peptidoglycan synthesis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

The structure of a new nucleoside antibiotic, capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on Novel Bacterial Translocase I Inhibitors, A-500359s. III. Deaminocaprolactam Derivatives of Capuramycin: A-500359 E, F, H, M-1 and M-2.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on novel bacterial translocase I inhibitors, A-500359s. V. Enhanced production of capuramycin and A-500359 A in Streptomyces griseus SANK 60196.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for characterization of Streptomyces species

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Biosynthesis of the tunicamycins: a review

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.71

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JA.2008.71

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19160520

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46152824&oldid=2207679692"